Lilly Asia & Shunwei Re-up in Aquablation Therapy
15 May 2024
US$ 19.00
Lilly Asia Ventures and Shunwei Capital have made a follow-on investment in the over Rmb60 million (US$8.3 million) ......
Related Publications
APER Jul 2024 - Season of Change...
A Data Report on Infrastructure in Asia...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.